| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/02/2000 | WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 03/02/2000 | WO2000010612A1 Methods to enhance and confine expression of genes |
| 03/02/2000 | WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 03/02/2000 | WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents |
| 03/02/2000 | WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 03/02/2000 | WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 03/02/2000 | WO2000010581A1 Rugs comprising butyric acid-producing bacterium combined with bile acid component |
| 03/02/2000 | WO2000010580A2 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 03/02/2000 | WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 03/02/2000 | WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 03/02/2000 | WO2000010550A2 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 03/02/2000 | WO2000010507A2 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 03/02/2000 | WO1999058552A3 Peptides that ellicit t, cellular immunity |
| 03/02/2000 | WO1999042088A3 Method for the treatment of diseases or disorders of the inner ear |
| 03/02/2000 | DE19838495A1 Artificial salivary gland useful for restoring salivary function comprises cultured salivary gland cells on a matrix |
| 03/02/2000 | CA2341903A1 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 03/02/2000 | CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents |
| 03/02/2000 | CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/02/2000 | CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 03/02/2000 | CA2341516A1 Cationic complexes of polymer-modified adenovirus |
| 03/02/2000 | CA2340929A1 Methods to enhance and confine expression of genes |
| 03/02/2000 | CA2340281A1 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 03/02/2000 | CA2337905A1 Targeted alphavirus and alphaviral vectors |
| 03/01/2000 | EP0982034A1 Composition comprising glucosamine and an extract of Perna canaliculus |
| 03/01/2000 | EP0981511A1 Methods and compositions for the selective modification of nucleic acids |
| 03/01/2000 | EP0981379A2 Artificial bodily fluid |
| 03/01/2000 | EP0981355A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin |
| 03/01/2000 | EP0981353A1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 03/01/2000 | EP0981352A1 Aplidine as an l-type calcium channel enhancer |
| 03/01/2000 | EP0981272A1 Prolonged cold storage of red blood cells by oxygen removal and additive usage |
| 03/01/2000 | EP0891419A4 Hematopoietic cell culture nutrient supplement |
| 03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
| 03/01/2000 | CN1246144A Clostridium butyricum having preventive and therapeutic effects on hepatopathy, and liver supporting agents, foods and feeds each containing culture medium thereof |
| 03/01/2000 | CN1246126A Antimicrobially active polypeptides |
| 03/01/2000 | CN1246056A Mycobacterium vaccae for down-regulation of THz activity of immune system |
| 03/01/2000 | CN1245717A Chinese patent medicine for curing diarrhea |
| 03/01/2000 | CN1245715A Yankang powder (paste) for relieving inflammation |
| 03/01/2000 | CN1245714A Medicine for curing hyperosteogeny |
| 03/01/2000 | CN1245706A Face-nourishing oral liquor and its preparation method |
| 03/01/2000 | CN1245704A Chinese pill for curing hyperosteogeny |
| 03/01/2000 | CN1245694A Hair-blackening and hair-growing capsule and its preparation method |
| 03/01/2000 | CN1245693A Chinese medicine powder Kangfusan for curing leukemia |
| 03/01/2000 | CN1245691A Chinese plaster for curing liver diseases and its preparation method |
| 03/01/2000 | CN1245690A Scorpion health-care wine |
| 03/01/2000 | CN1245689A Preparation method of bee afterbirth extract (bee frison extract) and its application |
| 03/01/2000 | CN1245688A Oral nutrient lead-expelling powdered granules |
| 03/01/2000 | CN1245687A Double regulation nutrient health-care product and its preparation method |
| 03/01/2000 | CN1049920C Method for preparation of snake wine |
| 03/01/2000 | CN1049834C Medicine for curing hepatitis and its prepn. process |
| 03/01/2000 | CN1049832C Medicine for curing lithiasis and its preparing method |
| 03/01/2000 | CN1049831C Plaster for curing hyperosteogeny |
| 03/01/2000 | CN1049830C Relifu hot application for stopping cancer pain |
| 03/01/2000 | CN1049829C Magnetic medicinal plaster for assuaging pain of person suffering from cancer |
| 03/01/2000 | CN1049828C Wulongsan powder |
| 03/01/2000 | CN1049827C Anti-cancer powder |
| 03/01/2000 | CN1049826C Medicine for curing rheumatism and its preparing method |
| 03/01/2000 | CN1049824C Anti-senility medicine and its preparing method |
| 03/01/2000 | CN1049823C Biological bacteriostat and its producing method |
| 03/01/2000 | CN1049822C Application of epidermal growth factor in preparing medicine for curing atrophic gastritis |
| 02/29/2000 | US6030943 Dehydrodidemnin B as an L-type calcium channel enhancer |
| 02/29/2000 | US6030767 Adding dye to whole blood or blood components such as erythrocytes or plasma, then irradiating with light of an appropriate intensity and wavelength for a sufficient time; for deactivating viruses, bacteria, parasites and leukocytes |
| 02/29/2000 | US6030635 Malleable paste for filling bone defects |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009179A2 Methods, instruments and materials for chondrocyte cell transplantation |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009153A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora |
| 02/24/2000 | WO2000002905A3 Methods for accelerating bone and cartilage growth and repair |
| 02/24/2000 | WO1999064565A3 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19837438A1 Recombinant human cell for forming bone and cartilage cells from undifferentiated mesenchyme is capable of expressing a member of the T-box family of transcription factors |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980428A2 TECHNIQUES AND COMPOSITIONS FOR TREATING HEART FAILURE AND VENTRICULAR REMODELING BY $i(IN VIVO) DELIVERY OF ANGIOGENIC TRANSGENES |
| 02/23/2000 | EP0980270A1 Dermal sheath tissue in wound healing |
| 02/23/2000 | EP0980264A2 Mammalian cell transduction for use in gene therapy |
| 02/23/2000 | EP0980263A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980249A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |